Navigation Links
Cordex Pharma Forms Heart Failure Medical Advisory Board
Date:2/11/2009

Dr. Joshua Hare to Chair the Board

LA JOLLA, Calif., Feb. 11 /PRNewswire-FirstCall/ -- Cordex Pharma, Inc. (OTC Bulletin Board: CDXP) announced today the formation of a Medical Advisory Board to provide clinical guidance for the Company's development program of CDP-1050 for the treatment of heart failure.

The Medical Advisory Board will play an important supportive role in the design and oversight of the planned CDP-1050 Phase 2 clinical trial and assist in addressing regulatory and patients' welfare issues. It is composed of internationally recognized leaders in the field of heart failure; all of whom have extensive experience in the design and execution of clinical trials aimed at improved care of patients with heart failure.

CDP-1050 is being developed as a new therapeutic modality in the management of heart failure. It targets the redox-nitiric oxide imbalance, which is increasingly recognized as a major factor in poor myocardial contractile efficiency, the hallmark manifestation of this disorder.

The Medical Advisory Board is chaired by Joshua M. Hare, M.D., the Louis Lemberg Professor of Medicine, Chief of the Division of Cardiology, and Director of the Interdisciplinary Stem Cell Institute at University of Miami, Miller School of Medicine. He has pioneered the use of stem cell therapy to repair damaged hearts. Dr. Hare has authored and co-authored numerous peer-reviewed publications including a report on a multi-center clinical trial with oxypurinol, a modifier of cellular redox potential, in patients with symptomatic heart failure. He served as the principal investigator of that clinical trial. Dr. Hare has also authored a New England Journal of Medicine editorial on redox-nitric oxide balance in the cardiovascular system.

Other members of the Medical Advisory Board include:

Wilson S. Colucci, M.D., is the Thomas J. Ryan Professor of
'/>"/>

SOURCE Cordex Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Cordex Pharma Presents New Frontiers in Cardiovascular Medicines on January 29
2. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
3. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
4. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
5. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
6. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...dge, Mass November 30, 2009 An international tea...otonics, and ETH Zrich have demonstrated compact, ... the invisible part of the light spectrum (infrare...t beam of a well-defined wavelength. The innovativ...ons related to remote chemical sensing pollution m...
(Date:11/30/2009)..., NEW YORK, Nov. 30 Th...ch (MJFF) today announced $1.5 million in total aw...ntially disease-modifying therapies for Parkinson,...l Approaches to Drug Discovery for Parkinson,s Dis...Corporation, plc (NYSE: ELN ), a neuroscience-ba...
(Date:11/30/2009)..., AMSTERDAM, November 30 Biop...y that the first patients have been enrolled in it...TIR(TM). The study is,designed to show reduction i...r following an allogeneic stem cell transplantatio...od cancer patients eligible for an allogeneic,stem...
(Date:11/30/2009)..., ROCKVILLE, Md., Nov. 30 /PRNewswire-FirstCall/ ...it has completed enrollment in the Phase II clinic.../2009 recommended strains) VLP vaccine candidate i...dults). This randomized, double-blind, active-con...y and immunogenicity of two different doses (15 mc...
Breaking Biology Technology:Scientists demonstrate multibeam, multi-functional lasers 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4
...NTA (Oct. 8, 2007) -- Nanoscale devices present a ...es just not enough room for light to travel in a s...roduced by radiating photons of light between two ...s 10 nanometers), smaller than the wavelength of t...noscale as its wavelength is interrupted, producin...
...on of Drug Pipeline and Advancement of Clinical Pr... Inc.,(OTC Bulletin Board: AVGO), a late-stage bio...ystem therapeutics for neurodegenerative,disorders...pany at the 4th,Annual BIO InvestorForum Conferenc...l of San Francisco. The company,s chief executive ...
...TON, Fla., Oct. 8 Biomedtex Inc. (Pink,Sheets: BM...company,announced today: BIOMEDTEX INC: The Comp...a broad,spectrum of global medical technologies, a...and promote innovations with significant commercia...visit us at http://WWW.BIOMEDTEX.COM Safe Harbo...
Other Biology Technology:Taming tiny, unruly waves for nano optics 2Avicena to Present at 4th Annual BIO InvestorForum Conference 2
(Date:11/30/2009)...s a colorless and odorless radioactive gas that is...um is a product of uranium decay and is found in t... and groundwater as well as building materials, pl...entration is expressed as the amount of radiation ...cts in a liter of air; thus the units are picocuri...
(Date:11/26/2009)...r their impressive antlers, red deer have been cau...deer,s antlers are much more than decorative. They... duelling. John Currey, from The University of Yor...ties of bone for over half a century and has becom...r through a long-standing collaboration with Tomas...
(Date:11/26/2009)...carried out in eight European countries has shown ... disease pandemic could have a significant role in...g in the open access journal BMC Infectious Disea...l days and weekends/holidays, finding that they we...rom Hasselt and Antwerp University, Belgium, led a...
Breaking Biology News(10 mins):Health Physics Society recommends considering action for indoor radon below current guidelines 2Tough yet stiff deer antler is materials scientist's dream 2School closure could reduce swine flu transmission by 21 percent 2Let Kids Sleep Late on Weekends to Fight Fat 3A Study 60231 1Let Kids Sleep Late on Weekends to Fight Fat 3A Study 60231 2Let Kids Sleep Late on Weekends to Fight Fat 3A Study 60231 3China Pharma Holdings Inc to Report Third Quarter 2009 Financial Results on November 12 2009 60226 1China Pharma Holdings Inc to Report Third Quarter 2009 Financial Results on November 12 2009 60226 2Winner Medicals Subsidiary Won Contribution in Chinese Nonwovens and Industrial Textiles Industry Award 60221 1Winner Medicals Subsidiary Won Contribution in Chinese Nonwovens and Industrial Textiles Industry Award 60221 2Winner Medicals Subsidiary Won Contribution in Chinese Nonwovens and Industrial Textiles Industry Award 60221 3
...Researchers at the Burnham Institute for Medical R... cellular stress caused by free radicals and accum...ell injury and death in neurodegenerative disorder... That link is Protein Disulphide Isomerase (PDI), ...rotein folding in times of cellular stress. Publi...
...The study of 18 HIV-positive subjects shows that H...tically different from HIV that lives in the blood...itive impairment among the study subjects was corr...in the HIV envelope gene. , The study appears i...sh K. Pillai, PhD, a staff research associate at S...
...Selfishness is not necessarily the best survival t...studying the comparative effectiveness of ,cheatin...n the journal Nature today, the team reports that ... benefits of cheating are eventually counterbalanc...nary theory, which states that in a competition fo...
Other Biology News:Key stress protein linked to toxicities responsible for Parkinson's, Alzheimer's 2Viral genetic differences are possible key to HIV dementia 2Viral genetic differences are possible key to HIV dementia 3Survival of the selfless - scientists find cheats don't always prosper 2
Flashlight-Trigger Solution from Assay Designs/Stressgen Bioreagents
...lity shift assay (EMSA) is a powerful tool for eva...o as gel shift or gel retardation, the assay is ba...ophoresis, free DNA will migrate differently than ...luminescent EMSA Kit is a nonradioactive system fo...
...real-time PCR detection system holds 48 x 0.2 ml t... independently excites fluorescence (470-500 nm) f...etects emitted light (523-543 nm and 540-700 nm). ... MJ Mini thermal cycler. System dimensions are 18 ...
... provide automated, higher throughput screening of...tubes. This flexible sample format makes the Guava...rch, target validation, assay development, and eve...uava PCA-96 uses a green laser detection system an...
Biology Products: